323.00
-2.47(-0.76%)
Currency In USD
| Previous Close | 325.47 |
| Open | 325.89 |
| Day High | 333.96 |
| Day Low | 322.01 |
| 52-Week High | 368.29 |
| 52-Week Low | 168.25 |
| Volume | 499,060 |
| Average Volume | 411,853 |
| Market Cap | 7.04B |
| PE | -12.9 |
| EPS | -25.04 |
| Moving Average 50 Days | 316 |
| Moving Average 200 Days | 265.42 |
| Change | -2.47 |
If you invested $1000 in Madrigal Pharmaceuticals, Inc. (MDGL) 10 years ago, it would be worth $3,893.91 as of February 05, 2025 at a share price of $323. Whereas If you bought $1000 worth of Madrigal Pharmaceuticals, Inc. (MDGL) shares 5 years ago, it would be worth $3,648.48 as of February 05, 2025 at a share price of $323.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Madrigal Pharmaceuticals Announces Preliminary* Fourth-Quarter and Full-Year 2024 Net Sales, Year-End Cash and Total Patients on Rezdiffra
GlobeNewswire Inc.
Jan 13, 2025 11:45 AM GMT
Preliminary fourth-quarter and full-year 2024 Rezdiffra™ (resmetirom) net sales ranges of $100 million to $103 million and $177 million to $180 million, respectivelyPreliminary year-end 2024 cash, cash equivalents, restricted cash and marketable secu
Madrigal Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 03, 2025 1:00 PM GMT
CONSHOHOCKEN, Pa., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the Company will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025 at 2:15 pm PT. The
Madrigal Pharmaceuticals, Inc. Announces Participation at Three Upcoming Investor Conferences
GlobeNewswire Inc.
Nov 06, 2024 1:00 PM GMT
CONSHOHOCKEN, Pa., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) today announced that the company will participate in fireside chats at three upcoming investor conferences: UBS Global Healthcare Conference 2024Wedn